Share
Preview
Svelland Capital now on Propel(x)
 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌
 
 
Investments on Propel(x) are high risk, illiquid and bear the risk of partial or complete loss of invested capital. Please review risk factors for investments on Propel(x) here.
This newsletter is for informational purposes only. It is not a solicitation to buy or sell a security.

Were you forwarded this newsletter? Subscribe here
28 October 2022
 
This newsletter begins with a few of our portfolio startups which have been in the news recently. After almost two years, we are hosting an in-person networking and deal flow mixer. If you are an accredited investor and local to the Bay area or are visiting, please register. This is a great opportunity to meet and connect with startups and a hedge fund featured on the Propel(x) platform. You get to meet the Propel(x) team too!

With a volatile stock market, high inflation, rising interest rates, supply chain issues and the energy crisis, if you believe Halloween has come early, our CEO has written two thought leadership pieces on valuations and portfolio diversification.

Enjoy the scroll down!
 
PORTFOLIO NEWS
Neocis* "secured $40 million in additional funding to continue transforming dental surgery with robotics. The oversubscribed $40M round was led by one of the dental industry’s largest specialist investors. They were joined by Intuitive Ventures, the independent VC arm of Intuitive Surgical that is accelerating the future of minimally invasive care. These new investors were joined by Neocis’ existing partners, bringing total investment in the Miami-based business to more than $160 million since its founding in 2009." Read more **

Repurpose*'s founder and CEO was featured as one of the 100 Women of Influence in 2022. Read more **

Cyberdontics*, a robotic dental surgery startup raised $15 million in Series A. The round was led by Pacific Dental Services, a dentist chain based in California. The venture backed startup plans to unveil its imaging process by 2023 and to introduce the robot within the next 2 years after getting regulatory approvals. Read more **

CAGE Bio* "announced the execution of a license agreement for development of TAGX-0003 for the targeted treatment of alopecia areata and vitiligo by dermatological application." Read more
**


Disclaimer - All these startups are Propel(x) alumni companies. They were either listed or fundraised through the Propel(x) platform via Propel(x)'s affiliated broker/dealer Hubble Investments.

* These links are gated and you will need to create a free account or sign in to view detailed information on the startup. This includes existing investors, pitch deck, deal terms, management information and much more.

** These links are provided solely as a convenience to readers and they do not imply an affiliation, sponsorship, endorsement, approval, investigation, verification, or monitoring by Hubble Investments or any of its affiliates of the contents on such third-party websites.
 
PLATFORM SPOTLIGHT
Svelland Capital now on Propel(x)

We are proud to bring you Svelland Global Trading Fund - a commodities trading hedge fund headquartered in the U.K.

Svelland Global Trading Fund (SGTF) is a global macro commodities focused hedge fund. With a three year compound annual return of 47.61% from 2019 - 2022, SGTF is the #2 ranked Global Macros Hedge Fund by Barclay Hedge Report 2022.

Qualified Purchasers on Propel(x) will have the ability to invest in this hedge fund at a low ticket size of $25,000 via an SPV created especially for this purpose.

Investors who participate may be able to take advantage of quarterly redemptions, subject to certain restrictions.
 
UPCOMING EVENTS
 
Deep Tech Investor Call | Virtual | 2 November - 9 AM PT

Weekly one-hour video calls to connect member investors with alternative investment opportunities. Only for accredited investors.

Investor Networking & Deal Flow Mixer | In Person | 17 November - 3 PM PT

Meet and connect with select startups and a hedge fund featured on the Propel(x) platform. Only for accredited investors.

If you have already registered for this event, we look forward to meeting you!

Click to tweet about this event

 
 
INVESTING INSIGHTS
 
The startup valuation party isn't over, but someone sure turned the music down
 
 
2021 saw unprecedented levels of VC activity with high valuations and record deal flows, resulting in quite the party for many startup founders. But economic headwinds have hit in 2022 with high inflation, rising interest rates, public market volatility, and uncertainty in the financial markets. The valuation party’s not over, but the excitement level has certainly dropped.
Out with 70-30 and in with 60-30-10
 
 
In today’s investment world, alternative investments have emerged from the shadows into the light of the mainstream. New technology and platforms have made alternative investments more accessible than at any time in history, bringing new opportunities for investors to rethink the traditional 70/30 (or 60/40, or thereabouts, depending on your risk profile) rule when it comes to the asset allocation of their portfolios.
For feedback and any questions, please write to us at marketing@propelx.com
Propel(x) is a digital alternative investment platform that enables accredited investors to invest in startups, venture funds and hedge funds. All securities offerings are done through Propel(x)’s affiliated broker-dealer, Hubble Investments.
Investments on Propel(x) are high risk, illiquid and bear the risk of partial or complete loss of invested capital. Please review risk factors for investments on Propel(x) here.
Email
 
Linkedin
 
Facebook
 
Twitter


Email Marketing by ActiveCampaign